Concepedia

Idarubicin appears equivalent to dose-intense daunorubicin for remission induction in patients with acute myeloid leukemia

Steven Trifilio, Zheng Zhou, Jayesh Mehta, Colleen Czerniak, Judy Pi, Deborah Greenberg, Molly Koslosky, Mihaela Pantiru, Jessica K. Altman

Leukemia Research · 2013 · 15 citations · 15 references

DOI

Concepts

References

15

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

Marilyn L. Slovak, Kenneth J. Kopecky, Peter A. Cassileth et al. · Blood · 2000 · 1.6K citations

, , +10

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

Panagiotis Kottaridis, Rosemary E. Gale, Marion E. Frew et al. · Blood · 2001 · 1.5K citations · Full text

, , +16

Anthracycline Dose Intensification in Acute Myeloid Leukemia

Hugo F. Fernández, Zhuoxin Sun, Xiaopan Yao et al. · New England Journal of Medicine · 2009 · 907 citations · Full text

, , +13

High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

Bob Löwenberg, Gert J. Ossenkoppele, Wim van Putten et al. · New England Journal of Medicine · 2009 · 822 citations · Full text

, , +17

Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia

Wiernik Ph, PL Banks, DC Jr Case et al. · Blood · 1992 · 451 citations · Full text

, , +15